ADA: Novel Insulin Offers Similar Results as Lantus

SAN FRANCISCO (MedPage Today) -- A new insulin glargine product proved to be noninferior to the top-selling Lantus in patients with type 1 and type 2 diabetes, researchers reported here.

Source: MedPage Today Cardiovascular - June 15, 2014 Category: Cardiology Source Type: news